Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?

Clinical and Experimental Metastasis

Volumn 31, Issue 5, 2014, Pages 535-541

  Hu, Qinghua ^a   Huang, Lingjin ^a   Kuang, Xuyuan ^b   Zhang, Heng ^a   Ling, Guoqiang ^a   Chen, Xuliang ^a   Li, Kejiang ^b   Deng, Zhenghao ^a   Zhou, Jianhua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Insulin like growth factor binding protein; Intratumor heterogeneity; Metastasis; Microvesicles; Non small cell lung cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 2;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURGERY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION;

AGED; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RISK FACTORS;

EID: 84902283897     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-014-9647-4     Document Type: Article

References (24)

1. Gao J, Chang YS, Jallal B, Viner J (2012) Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology. Cancer Res 73:3-12
2. Holmes KM, Annala M, Chua CY et al (2012) Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network. Proc Natl Acad Sci USA 109:3475-3480
3. Probst-Hensch NM, Steiner JH, Schraml P et al (2010) IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clin Cancer Res 16:1025-1032
4. Lancaster JM, Sayer RA, Blanchette C et al (2006) High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer 16:1529-1535
5. Uzoh CC, Holly JM, Biernacka KM et al (2011) Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel. Br J Cancer 104:1587-1593
6. Ladd JJ, Busald T, Johnson MM et al (2012) Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila) 5:655-664
7. Lee DY, Kim SJ, Lee YC (1999) Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients. J Korean Med Sci 14:401-404
8. Yu CJ, Wang CL, Wang CI et al (2011) Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res 10:4671-4682
9. Matuschek C, Rudoy M, Peiper M et al (2011) Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients. Eur J Med Res 16:451-456
10. Reeve JG, Morgan J, Schwander J, Bleehen NM (1993) Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Cancer Res 53:4680-4685
11. Yazawa T, Sato H, Shimoyamada H et al (2009) Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer. Am J Pathol 175:976-987
12. Yazawa T, Sato H, Shimoyamada H et al (2007) Growth regulation via insulin-like growth factor binding protein-4 and -2 in lung epithelial cells and cancers. J Thorac oncol 2:S551-S556
13. Kay F, Saskia G, Holger E, Walter J (1993) Overexpression of p53 and prognosis in breast cancer. Cancer 72:3641-3647
14. Haqqani AS, Delaney CE, Tremblay TL et al (2013) Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 10:4-10
15. Herbert Yu, Rohan Thomas (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472-1489
16. Sato H, Yazawa T, Suzuki T et al (2006) Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. Am J Pathol 169:1550-1566
17. Migita T, Narita T, Asaka R et al (2010) Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3. Am J Pathol 176:1756-1766
18. Azar WJ, Azar SH, Higgins S et al (2011) IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology 152:3332-3342
19. Azar WJ, Zivkovic S, Werther GA, Russo VC (2013) IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells. Oncogene 25:1-11
20. Russo VC, Schütt BS, Andaloro E et al (2005) Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology 146:4445-4455
21. Png KJ, Halberg N, Yoshida M, Tavazoie SF (2011) A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190-194
22. Guo C, Lu H, Gao W et al (2013) Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS ONE 8:e74973-e74980
23. Martins VR, Dias MS, Hainaut P (2013) Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 25:66-75
24. Swanton C (2012) Intratumor heterogeneity: evolution through space and time. Cancer Res 72:4875-4882